Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

A Case-Control Study of the Association between Polymorphisms in the Fibrinogen Alpha Chain Gene and Schizophrenia.

Rao W, Zhou N, Zhang H, Liu R, Zhang S, Su Y, Yang G, Ma Y, Shi J, Yu Y, Yu Q.

Dis Markers. 2017;2017:3104180. doi: 10.1155/2017/3104180. Epub 2017 Jan 19.

2.

Defective phosphoinositide metabolism in autism.

Gross C.

J Neurosci Res. 2017 May;95(5):1161-1173. doi: 10.1002/jnr.23797. Epub 2016 Jul 4. Review.

PMID:
27376697
3.

A catalog of hemizygous variation in 127 22q11 deletion patients.

Hestand MS, Nowakowska BA, Vergaelen E, Van Houdt J, Dehaspe L, Suhl JA, Del-Favero J, Mortier G, Zackai E, Swillen A, Devriendt K, Gur RE, McDonald-McGinn DM, Warren ST, Emanuel BS, Vermeesch JR.

Hum Genome Var. 2016 Jan 14;3:15065. doi: 10.1038/hgv.2015.65. eCollection 2016.

4.

Genetic deletion of fibroblast growth factor 14 recapitulates phenotypic alterations underlying cognitive impairment associated with schizophrenia.

Alshammari TK, Alshammari MA, Nenov MN, Hoxha E, Cambiaghi M, Marcinno A, James TF, Singh P, Labate D, Li J, Meltzer HY, Sacchetti B, Tempia F, Laezza F.

Transl Psychiatry. 2016 May 10;6:e806. doi: 10.1038/tp.2016.66.

5.

Transcriptome alterations of mitochondrial and coagulation function in schizophrenia by cortical sequencing analysis.

Huang KC, Yang KC, Lin H, Tsao TT, Lee SA.

BMC Genomics. 2014;15 Suppl 9:S6. doi: 10.1186/1471-2164-15-S9-S6. Epub 2014 Dec 8.

6.

Modulation of the FGF14:FGF14 homodimer interaction through short peptide fragments.

Ali S, Shavkunov A, Panova N, Stoilova-McPhie S, Laezza F.

CNS Neurol Disord Drug Targets. 2014;13(9):1559-70.

7.

Association between autism spectrum disorder in individuals with velocardiofacial (22q11.2 deletion) syndrome and PRODH and COMT genotypes.

Radoeva PD, Coman IL, Salazar CA, Gentile KL, Higgins AM, Middleton FA, Antshel KM, Fremont W, Shprintzen RJ, Morrow BE, Kates WR.

Psychiatr Genet. 2014 Dec;24(6):269-72. doi: 10.1097/YPG.0000000000000062.

8.

Genetic variations of PIP4K2A confer vulnerability to poor antipsychotic response in severely ill schizophrenia patients.

Kaur H, Jajodia A, Grover S, Baghel R, Gupta M, Jain S, Kukreti R.

PLoS One. 2014 Jul 15;9(7):e102556. doi: 10.1371/journal.pone.0102556. eCollection 2014.

9.

Association of GRM3 polymorphism with white matter integrity in schizophrenia.

Mounce J, Luo L, Caprihan A, Liu J, Perrone-Bizzozero NI, Calhoun VD.

Schizophr Res. 2014 May;155(1-3):8-14. doi: 10.1016/j.schres.2014.03.003. Epub 2014 Mar 26.

10.

Serotonin Transporter Promoter Region (5-HTTLPR) Polymorphism Is Not Associated With Paroxetine-Induced Ejaculation Delay in Dutch Men With Lifelong Premature Ejaculation.

Janssen PK, Zwinderman AH, Olivier B, Waldinger MD.

Korean J Urol. 2014 Feb;55(2):129-33. doi: 10.4111/kju.2014.55.2.129. Epub 2014 Feb 14.

11.

Genome-wide association analysis with gray matter volume as a quantitative phenotype in first-episode treatment-naïve patients with schizophrenia.

Wang Q, Xiang B, Deng W, Wu J, Li M, Ma X, Wang Y, Jiang L, McAlonan G, Chua SE, Sham PC, Hu X, Li T.

PLoS One. 2013 Sep 24;8(9):e75083. doi: 10.1371/journal.pone.0075083. eCollection 2013. Erratum in: PLoS One. 2015;10(4):e0122945.

12.

Biomarker investigations related to pathophysiological pathways in schizophrenia and psychosis.

Chana G, Bousman CA, Money TT, Gibbons A, Gillett P, Dean B, Everall IP.

Front Cell Neurosci. 2013 Jun 26;7:95. doi: 10.3389/fncel.2013.00095. eCollection 2013.

13.

Personalized medicine in psychiatry: problems and promises.

Ozomaro U, Wahlestedt C, Nemeroff CB.

BMC Med. 2013 May 16;11:132. doi: 10.1186/1741-7015-11-132. Review.

14.

Mammalian phosphatidylinositol 4-kinases as modulators of membrane trafficking and lipid signaling networks.

Clayton EL, Minogue S, Waugh MG.

Prog Lipid Res. 2013 Jul;52(3):294-304. doi: 10.1016/j.plipres.2013.04.002. Epub 2013 Apr 19. Review.

15.

MicroRNA-382 expression is elevated in the olfactory neuroepithelium of schizophrenia patients.

Mor E, Kano S, Colantuoni C, Sawa A, Navon R, Shomron N.

Neurobiol Dis. 2013 Jul;55:1-10. doi: 10.1016/j.nbd.2013.03.011. Epub 2013 Mar 29.

16.

Expression of the G72/G30 gene in transgenic mice induces behavioral changes.

Cheng L, Hattori E, Nakajima A, Woehrle NS, Opal MD, Zhang C, Grennan K, Dulawa SC, Tang YP, Gershon ES, Liu C.

Mol Psychiatry. 2014 Feb;19(2):175-83. doi: 10.1038/mp.2012.185. Epub 2013 Jan 22.

17.

Genotype-phenotype correlation in 22q11.2 deletion syndrome.

Michaelovsky E, Frisch A, Carmel M, Patya M, Zarchi O, Green T, Basel-Vanagaite L, Weizman A, Gothelf D.

BMC Med Genet. 2012 Dec 17;13:122. doi: 10.1186/1471-2350-13-122.

18.
19.

Atlas-based white matter analysis in individuals with velo-cardio-facial syndrome (22q11.2 deletion syndrome) and unaffected siblings.

Radoeva PD, Coman IL, Antshel KM, Fremont W, McCarthy CS, Kotkar A, Wang D, Shprintzen RJ, Kates WR.

Behav Brain Funct. 2012 Aug 1;8:38. doi: 10.1186/1744-9081-8-38.

20.

A gene co-expression network in whole blood of schizophrenia patients is independent of antipsychotic-use and enriched for brain-expressed genes.

de Jong S, Boks MP, Fuller TF, Strengman E, Janson E, de Kovel CG, Ori AP, Vi N, Mulder F, Blom JD, Glenthøj B, Schubart CD, Cahn W, Kahn RS, Horvath S, Ophoff RA.

PLoS One. 2012;7(6):e39498. doi: 10.1371/journal.pone.0039498. Epub 2012 Jun 27.

Supplemental Content

Support Center